Survival and causes of death in patients with alpha and beta-thalassemia in Northern Thailand

References

• Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):1–9. doi: 10.1016/S0140-6736(17)31822-6.
   PubMed Web of Science ®Google Scholar
• Guidelines for the management of transfusion dependent thalassaemia (TDT). 4th ed. Nicosia: Thalassaemia International Federation; 2021.
   Google Scholar
• Guidelines for the management of non transfusion dependent thalassaemia (NTDT). 2nd ed. Nicosia: Thalassaemia International Federation; 2017.
   Google Scholar
• Gluba-Brzozka A, Franczyk B, Rysz-Gorzynska M, et al. Pathomechanisms of immunological disturbances in beta-thalassemia. Int J Mol Sci. 2021;22:9677.
   PubMed Web of Science ®Google Scholar
• Sakran W, Levin C, Kenes Y, et al. Clinical spectrum of serious bacterial infections among splenectomized patients with hemoglobinopathies in Israel: a 37-year follow-up study. Infection. 2012;40(1):35–39. doi: 10.1007/s15010-011-0178-5.
   PubMed Web of Science ®Google Scholar
• Vento S, Cainelli F, Cesario F. Infections and thalassaemia. Lancet Infect Dis. 2006;6(4):226–233. doi: 10.1016/S1473-3099(06)70437-6.
   PubMed Web of Science ®Google Scholar
• Borgna-Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054(1):40–47. doi: 10.1196/annals.1345.006.
   PubMedGoogle Scholar
• Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193.
   PubMed Web of Science ®Google Scholar
• Ladis V, Chouliaras G, Berdousi H, et al. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci. 2005;1054(1):445–450. doi: 10.1196/annals.1345.067.
   PubMedGoogle Scholar
• Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000;355(9220):2051–2052. doi: 10.1016/S0140-6736(00)02357-6.
   PubMed Web of Science ®Google Scholar
• Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10(1):42. doi: 10.1186/1532-429X-10-42.
   PubMedGoogle Scholar
• Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994;331(9):574–578. doi: 10.1056/NEJM199409013310903.
   PubMed Web of Science ®Google Scholar
• Roudbari M, Soltani-Rad M, Roudbari S. The survival analysis of beta thalassemia major patients in South East of Iran. Saudi Med J. 2008;29:1031–1035.
   PubMedGoogle Scholar
• Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2(8653):27–30. doi: 10.1016/s0140-6736(89)90264-x.
   PubMed Web of Science ®Google Scholar
• Ehlers KH, Giardina PJ, Lesser ML, et al. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine. J Pediatr. 1991;118(4 Pt 1):540–545. doi: 10.1016/s0022-3476(05)83374-8.
   PubMed Web of Science ®Google Scholar
• Porter JB, Davis BA. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol. 2002;15(2):329–368. doi: 10.1016/S1521-6926(02)90214-8.
   PubMed Web of Science ®Google Scholar
• Premawardhena AP, Ediriweera DS, Sabouhanian A, et al. Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study. Lancet Glob Health. 2022;10(1):e134–e141. doi: 10.1016/S2214-109X(21)00446-0.
   PubMed Web of Science ®Google Scholar
• Donze C, Benoit A, Thuret I, et al. Beta-thalassemia in childhood: current state of health in a high-income country. Br J Haematol. 2023;201(2):334–342. doi: 10.1111/bjh.18631.
   PubMed Web of Science ®Google Scholar
• Jobanputra M, Paramore C, Laird SG, et al. Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis. Br J Haematol. 2020;191(5):897–905. doi: 10.1111/bjh.17091.
   PubMed Web of Science ®Google Scholar
• Mohd Ibrahim H, Muda Z, Othman IS, et al. Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry. BMJ Open. 2020;10(6):e037974. doi: 10.1136/bmjopen-2020-037974.
   PubMed Web of Science ®Google Scholar
• Musallam KM, Vitrano A, Meloni A, et al. Survival and causes of death in 2,033 patients with non-transfusion-dependent beta-thalassemia. Haematologica. 2021;106(9):2489–2492. doi: 10.3324/haematol.2021.278684.
   PubMed Web of Science ®Google Scholar
• Mankhemthong K, Phusua A, Suanta S, et al. Molecular characteristics of thalassemia and hemoglobin variants in prenatal diagnosis program in Northern Thailand. Int J Hematol. 2019;110(4):474–481. doi: 10.1007/s12185-019-02694-y.
   PubMed Web of Science ®Google Scholar
• Winichakoon P, Tantiworawit A, Rattanathammethee T, et al. Prevalence and risk factors for complications in patients with nontransfusion dependent alpha- and beta-thalassemia. Anemia. 2015;2015:793025–793027. doi: 10.1155/2015/793025.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi: 10.1093/eurheartj/ehw128.
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. doi: 10.1093/eurheartj/ehv317.
   PubMed Web of Science ®Google Scholar
• Sudhas Na Ayuthya P, Pongpanich B, Damrongwatna T, et al. Cardiac study in thalassemic children. Birth Defects Orig Artic Ser. 1987;23:351–354.
   PubMedGoogle Scholar
• Tantiworawit A, Tapanya S, Phrommintikul A, et al. Prevalence and risk factors for cardiac iron overload and cardiovascular complications among patients with thalassemia in Northern Thailand southeast. Asian J Trop Med Public Health. 2016;47:1335–1342.
   PubMed Web of Science ®Google Scholar
• Kountouris P, Michailidou K, Christou S, et al. Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus. Haematologica. 2021;106:2458–2468.
   PubMed Web of Science ®Google Scholar
• Dhanya R, Sedai A, Ankita K, et al. Life expectancy and risk factors for early death in patients with severe thalassemia syndromes in South India. Blood Adv. 2020;4:1448–1457.
   PubMed Web of Science ®Google Scholar
• Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21(6):327–348. doi: 10.1016/j.blre.2007.07.003.
   PubMed Web of Science ®Google Scholar
• Vinchi F, Sparla R, Passos S, et al. Transfusion-induced impairment of macrophage responses is partially restored by the iron chelator deferasirox. Blood. 2018;132(Supplement 1):3625–3625. doi: 10.1182/blood-2018-99-113016.
   Google Scholar
• Piyajaroenkij T, Tantiworawit A, Khikhuntod J, et al. Alteration of monocyte subsets and their functions in thalassemia patients. Int J Hematol. 2023;117(2):188–197. doi: 10.1007/s12185-022-03484-9.
   PubMed Web of Science ®Google Scholar
• Bisharat N, Omari H, Lavi I, et al. Risk of infection and death among post-splenectomy patients. J Infect. 2001;43(3):182–186. doi: 10.1053/jinf.2001.0904.
   PubMed Web of Science ®Google Scholar
• Kimmig LM, Palevsky HI. Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc. 2016;13(6):945–954. doi: 10.1513/AnnalsATS.201512-826FR.
   PubMed Web of Science ®Google Scholar
• Chueamuangphan N. Pulmonary arterial hypertension in beta-thalassemia. J Hematol Transfus Med. 2009;19:101–108.
   Google Scholar
• Osataphan N, Dumnil S, Tantiworawit A, et al. The long-term efficacy in blood transfusions, hematologic parameter changes, and complications after splenectomy in patients with transfusion-dependent thalassemia. Transfus Apher Sci. 2022;62(3):103620. doi: 10.1016/j.transci.2022.103620.
   PubMed Web of Science ®Google Scholar